PRETERM LABOR
Preterm labor by definition occurs between 20
and 37 weeks of gestation and is the most common com-plication of the third
trimester. Approximately 8% of live-born infants in the United States are
deliv-ered before term. Important contributory maternal factors include
extremes of age, inadequate prenatal care, unusual body habitus, increased
physical activ-ity, infections, prior preterm labor, multiple gesta-tion, and
other medical illnesses or complications during pregnancy.
Because of their small size and incomplete development, preterm
infants—particularly those less than 30 weeks of gestational age or weighing
less than 1500 g—experience a greater number of complications than term
infants. Premature rupture of membranes complicates one third of premature
deliveries; the combination of premature rupture of membranes and premature
labor increases the like-lihood of umbilical cord compression resulting in
fetal hypoxemia and asphyxia. Preterm infants with a breech presentation are
particularly prone to pro-lapse of the umbilical cord during labor. Moreover,
inadequate production of pulmonary surfactant fre-quently leads to the
idiopathic respiratory distress syndrome (hyaline membrane disease) after
deliv-ery. Surfactant levels are generally adequate only after week 35 of
gestation. Lastly, a soft, poorly calci-fied cranium predisposes these neonates
to intracra-nial hemorrhage during vaginal delivery.
When preterm labor occurs before 35 weeks of
gestation, bed rest and tocolytic therapy are usually initiated. Treatment is
successful in 75% of patients. Labor is inhibited until the lungs mature and
suffi-cient pulmonary surfactant is produced, as judged by amniocentesis. The
risk of respiratory distress syndrome is markedly reduced when the amniotic
fluid lecithin/sphingomyelin ratio is greater than 2. Glucocorticoid
(betamethasone) may be given to induce production of pulmonary surfactant,
which requires a minimum of 24–48 h. The most com-monly used tocolytics are β2-adrenergic
agonists (ritodrine or terbutaline) and magnesium (6 g intra-venously over 30
min followed by 2–4 g/h). Ritodrine (given intravenously as 100–350 mcg/min)
and ter-butaline (given orally as 2.5–5 mg every 4–6 h) also have some β1-adrenergic
receptor activity, which accounts for some of their side effects. Maternal side
effects include tachycardia, arrhythmias, myo-cardial ischemia, mild hypotension,
hyperglycemia, hypokalemia, and, rarely, pulmonary edema. Other tocolytic
agents include calcium channel blockers (nifedipine), prostaglandin synthetase
inhibitors,oxytocin antagonists (atosiban), and possibly nitric oxide. Fetal
ductal constriction can occur after 32 weeks of gestation with nonsteroidal
antiinflam-matory drugs such as indomethacin, but it is usually transient and
resolves after discontinuation of the drug; renal impairment in the fetus may
also cause oligohydramnios.
When tocolytic therapy fails to arrest labor,
anesthesia often becomes necessary. The goal dur-ing vaginal delivery of a
preterm fetus is a slow con-trolled delivery with minimal pushing by the
mother. An episiotomy and low forceps are often employed. Spinal or epidural
anesthesia allows complete pel-vic relaxation. Cesarean section is performed
for fetal distress, breech presentation, intrauterine growth retardation, or
failure of labor to progress. Residual effects from β-adrenergic agonists may complicate general anesthesia. The half-life of
rito-drine may be as long as 3 h. Ketamine and ephed-rine (and halothane)
should be used cautiously due to interaction with tocolytics. Hypokalemia is
usu-ally due to an intracellular uptake of potassium and rarely requires
treatment; however, it may increase sensitivity to muscle relaxants. Magnesium
therapy potentiates muscle relaxants and may predispose to hypotension
(secondary to vasodilation). Residual effects from tocolytics interfere with
uterine con-traction following delivery. Lastly, preterm new-borns are often
depressed at delivery and frequently need resuscitation. Preparations for
resuscitation should be completed prior to delivery.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.